6-Fluoroanthranilic acid

[Description]:

[Related Catalog]:

[In Vitro]

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
308.8±27.0 °C at 760 mmHg

[ Melting Point ]:
167-169 °C(lit.)

[ Molecular Formula ]:
C₇H₆FNO₂

[ Molecular Weight ]:
155.13

[ Flash Point ]:
140.5±23.7 °C

[ Exact Mass ]:
155.038254

[ PSA ]:
63.32000

[ LogP ]:
1.57

[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C

[ Index of Refraction ]:
1.606

Click to get detail MSDS

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26-S36-S37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2922499990

Click to get detail synthetic route

Precursor

DownStream

[ HS Code ]: 2922499990

[ Summary ]:
HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.

J. Med. Chem. 39 , 1172, (1996)

A series of substituted (4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide derivatives was prepared and evaluated as potential atypical antipsychotic agents. The target compounds were readi...

More Articles